MoneyWorks4Me

Lyka Labs - Quaterly Results

08 Aug 2022 Evaluate
The sales moved down -49.67% to Rs. 218.78 millions for the June 2022 quarter as compared to Rs. 434.66 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2022 dipped to Rs. 3.27  millions from Rs. 196.45 millions  in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 66.04 millions from 303.37 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 218.78 434.66 -49.67 218.78 434.66 -49.67 1643.49 622.63 163.96
Other Income 6.84 5.31 28.81 6.84 5.31 28.81 27.20 22.10 23.08
PBIDT 66.04 303.37 -78.23 66.04 303.37 -78.23 1002.19 166.35 502.46
Interest 28.01 68.90 -59.35 28.01 68.90 -59.35 199.21 255.53 -22.04
PBDT 38.02 234.47 -83.78 38.02 234.47 -83.78 756.30 -103.47 -830.94
Depreciation 34.14 20.52 66.37 34.14 20.52 66.37 153.89 80.50 91.17
PBT 3.88 213.95 -98.19 3.88 213.95 -98.19 602.41 -183.97 -427.45
TAX 0.61 17.50 -96.51 0.61 17.50 -96.51 203.38 -39.36 -616.72
Deferred Tax 0.61 17.50 -96.51 0.61 17.50 -96.51 203.38 -39.36 -616.72
PAT 3.27 196.45 -98.34 3.27 196.45 -98.34 399.03 -144.61 -375.94
Equity 286.90 286.90 0.00 286.90 286.90 0.00 286.90 286.90 0.00
PBIDTM(%) 30.19 69.79 -56.75 30.19 69.79 -56.75 60.98 26.72 128.24
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..